Overview
Quality and sustainability go hand in hand in keeping with our commitment to transparency and continuous improvement within our GMP (Good Manufacturing Practice) Facility – from farm production, science, manufacturing, distribution, security and product delivery to local and global markets.
“Current New Zealand numbers estimate 160,000+ patients are using cannabis as a medicine.”
Oncologist Dr Anthony Falkar states that between 40-60% of his patients are using this product obtained via the black market.
Our People
It is our belief and responsibility that everybody who works within the Med Green Pharmaceutical framework does so in a fair, safe, nondiscriminatory and empowering environment. Our people and their wellness are our reason for being.
Facilities Update – Oct 2018
Looking ahead to 2019, and after 4 years of meticulous planning, we are well underway in building great value in... read more →
October 25, 2018
New Labor bill would make using and growing cannabis legal in Canberra
It's the illicit drug one in three have used in their lifetime, but could lighting up a joint soon be... read more →
September 26, 2018
Medicinal cannabis: A welcome relief?
Dr Fiona Hutton and Dr Denise Taylor ask why legalisation of cannabis for medical purposes is so controversial in New... read more →
September 26, 2018
The medicinal cannabis conundrum.
The word ‘cannabis’ polarises opinions in countries around the world, and New Zealand is no exception. A popular belief is... read more →
September 26, 2018